Devos D - Search Results

1

Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.

Santin MDN, Voulleminot P, Vrillon A, Hainque E, Béreau M, Lagha-Boukbiza O, Wirth T, Montaut S, Bardinet E, Kyheng M, Rolland AS, Voirin J, Drapier S, Durif F, Eusebio A, Giordana C, Auzou N, Houeto JL, Hubsch C, Jarraya B, Laurencin C, Maltete D, Meyer M, Rascol O, Rouaud T, Tir M, Moreau C, Corvol JC, Proust F, Grabli D, Devos D, Tranchant C, Anheim M; Predistim Study Group. Santin MDN, et al. Among authors: devos d. Mov Disord. 2021 Mar;36(3):750-757. doi: 10.1002/mds.28320. Epub 2020 Oct 6. Mov Disord. 2021. PMID: 33022101

2

Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.

Dujardin K, Devos D, Duhem S, Destée A, Marié RM, Durif F, Lacomblez L, Touchon J, Pollak P, Péré JJ. Dujardin K, et al. Among authors: devos d. J Neurol. 2006 Sep;253(9):1154-9. doi: 10.1007/s00415-006-0175-2. Epub 2006 Sep 22. J Neurol. 2006. PMID: 16998649 Clinical Trial.

3

Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.

Devos D, Defebvre L. Devos D, et al. Prog Brain Res. 2006;159:331-49. doi: 10.1016/S0079-6123(06)59022-3. Prog Brain Res. 2006. PMID: 17071241

4

Characteristics of apathy in Parkinson's disease.

Dujardin K, Sockeel P, Devos D, Delliaux M, Krystkowiak P, Destée A, Defebvre L. Dujardin K, et al. Among authors: devos d. Mov Disord. 2007 Apr 30;22(6):778-84. doi: 10.1002/mds.21316. Mov Disord. 2007. PMID: 17290451

5

Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.

Clement F, Devos D, Moreau C, Coubes P, Destee A, Defebvre L. Clement F, et al. Among authors: devos d. Acta Neurol Belg. 2007 Mar;107(1):26-31. Acta Neurol Belg. 2007. PMID: 17569231

6

Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.

Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Destée A, Defebvre L, Krystkowiak P. Tir M, et al. Among authors: devos d. Neurosurgery. 2007 Aug;61(2):297-304; discussion 304-5. doi: 10.1227/01.NEU.0000285347.50028.B9. Neurosurgery. 2007. PMID: 17762742 Clinical Trial.

7

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.

Devos D, Dujardin K, Poirot I, Moreau C, Cottencin O, Thomas P, Destée A, Bordet R, Defebvre L. Devos D, et al. Mov Disord. 2008 Apr 30;23(6):850-7. doi: 10.1002/mds.21966. Mov Disord. 2008. PMID: 18311826 Clinical Trial.

8

STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.

Moreau C, Defebvre L, Destée A, Bleuse S, Clement F, Blatt JL, Krystkowiak P, Devos D. Moreau C, et al. Among authors: devos d. Neurology. 2008 Jul 8;71(2):80-4. doi: 10.1212/01.wnl.0000303972.16279.46. Epub 2008 Apr 16. Neurology. 2008. PMID: 18420482

9

Levodopa for Parkinson's disease.

Devos D, Moreau C, Destée A. Devos D, et al. N Engl J Med. 2009 Feb 26;360(9):935-6; author reply 936. doi: 10.1056/NEJMc082718. N Engl J Med. 2009. PMID: 19246370 No abstract available.

10

Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.

Devos D; French DUODOPA Study Group. Devos D, et al. Mov Disord. 2009 May 15;24(7):993-1000. doi: 10.1002/mds.22450. Mov Disord. 2009. PMID: 19253412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

412 results

Search Page